Kanawha Capital Management LLC Buys 1,432 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Kanawha Capital Management LLC raised its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 20.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 8,384 shares of the financial services provider’s stock after acquiring an additional 1,432 shares during the quarter. Kanawha Capital Management LLC’s holdings in iShares Biotechnology ETF were worth $1,221,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Williams Financial LLC purchased a new position in iShares Biotechnology ETF in the second quarter valued at approximately $867,000. PVG Asset Management Corp purchased a new position in shares of iShares Biotechnology ETF during the 2nd quarter valued at $415,000. Oppenheimer & Co. Inc. grew its stake in shares of iShares Biotechnology ETF by 7.6% during the 1st quarter. Oppenheimer & Co. Inc. now owns 35,747 shares of the financial services provider’s stock worth $4,905,000 after acquiring an additional 2,532 shares during the period. PFG Advisors grew its stake in shares of iShares Biotechnology ETF by 3.9% during the 1st quarter. PFG Advisors now owns 4,655 shares of the financial services provider’s stock worth $639,000 after acquiring an additional 173 shares during the period. Finally, Geneos Wealth Management Inc. increased its holdings in iShares Biotechnology ETF by 113.1% in the 1st quarter. Geneos Wealth Management Inc. now owns 946 shares of the financial services provider’s stock worth $130,000 after acquiring an additional 502 shares during the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Stock Up 1.8 %

NASDAQ IBB opened at $142.78 on Monday. iShares Biotechnology ETF has a 52 week low of $113.56 and a 52 week high of $150.57. The firm’s 50-day simple moving average is $145.02 and its two-hundred day simple moving average is $140.46.

iShares Biotechnology ETF Announces Dividend

The firm also recently declared a dividend, which was paid on Monday, September 30th. Investors of record on Wednesday, September 25th were paid a dividend of $0.2005 per share. The ex-dividend date of this dividend was Wednesday, September 25th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.